查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1598813

疫苗管瓶監測器市場：按類型、應用分類 - 2025-2030 年全球預測

Vaccine Vial Monitor Market by Type (Multi-Dose, Single Dose), Application (Preventive Vaccine, Therapeutic Vaccine) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 189 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年疫苗管瓶監測器市值為2.2425億美元，預計2024年將達到2.7538億美元，複合年成長率為22.89%，到2030年將達到9.4927億美元。

疫苗管瓶監測器 (VVM) 是放置在疫苗管瓶上的小型設備，透過改變顏色來指示疫苗是否受熱影響，進而影響功效。對監測卡的需求源於維持疫苗分發中的低溫運輸以確保維持疫苗功效的至關重要性。無論是在已開發國家還是開發中國家，維持最佳儲存條件是一項挑戰。最終用戶通常包括醫療保健提供者、醫院、診所和政府免疫計劃。 VVM 市場的成長受到疫苗宣傳活動的增加、對疫苗功效重要性的認知不斷提高以及監測敏感性技術進步的影響。此外，全球政府和非政府對免疫計畫的支持不斷增加也支撐了需求。然而，VVM 技術的高成本以及某些地區對其優勢的認知有限等挑戰可能會影響市場擴張。此外，廣泛使用此類監視器需要依賴一致的供應鏈，而該供應鏈在不利條件下可能會中斷。

主要市場統計
基準年[2023] 2.2425億美元
預測年份 [2024] 27538萬美元
預測年份 [2030] 9.4927 億美元
複合年成長率（%） 22.89%

有機會將 VVM 的應用擴展到其他溫度敏感藥物，並增加開拓市場的採用，特別是在醫療基礎設施薄弱的地區。公司可以透過開發支援即時監控和資料登錄的數位整​​合監測卡來創新並支援更好地管理疫苗分銷網路。探索成本更低但同樣有效的監測卡材料有助於降低製造成本並使監測卡更容易獲得。競爭是 VVM 市場的本質，科技公司和醫療保健提供者有合作增強設備能力的空間。公司可以透過投資培訓計劃來提高相關人員的知識並利用夥伴關係關係來加強銷售管道，從而實現策略擴張。

市場動態：針對快速發展的疫苗管瓶監測器市場揭示的關鍵市場見解

供需因素的動態交互作用正在改變疫苗管瓶監測器市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時消費行為及其對製造成本的影響以及對採購趨勢的影響。

  • 市場促進因素
    • 疫苗安全管理的需求與重要性
    • 需要適當監測疫苗管瓶
    • 感染疾病高發生率及加大疫苗接種力度
  • 市場限制因素
    • 應用和物流問題
  • 市場機會
    • 疫苗管瓶監控器與低溫運輸基礎設施之間的關係
    • 醫療衛生部門加大力度提升偏遠地區醫療服務便利度
  • 市場挑戰
    • VVM 的謹慎監管考慮

波特的五力：駕馭疫苗管瓶監測器市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解疫苗管瓶監測器市場的外部影響

外部宏觀環境因素在塑造疫苗管瓶監測器市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解疫苗管瓶監測器市場的競爭狀況

疫苗管瓶監視器市場的詳細市場佔有率分析可以對供應商的業績進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣疫苗管瓶監視器市場供應商的績效評估

FPNV 定位矩陣是評估疫苗管瓶監測器市場供應商的關鍵工具。此矩陣允許業務組織根據商務策略和產品滿意度評估供應商，從而做出與其目標相符的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議繪製疫苗管瓶監測器市場的成功之路

對於旨在加強在全球市場的影響力的公司來說，對疫苗管瓶監測儀市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 疫苗接種的需求與安全使用的重要性
      • 需要適當監測疫苗管瓶
      • 感染疾病傳播加劇及疫苗接種推廣工作
    • 抑制因素
      • 應用和物流相關問題
    • 機會
      • 疫苗管瓶監控器與低溫運輸基礎設施之間的關係
      • 加強醫療衛生領域工作，提高偏遠地區醫療服務可近性
    • 任務
      • VVM 的嚴格監管考慮
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章疫苗管瓶監測器市場：依類型

  • 多劑量
  • 單一劑量

第7章疫苗管瓶監測器市場：依應用分類

  • 預防性疫苗
  • 治療性疫苗

第8章北美和南美疫苗管瓶監測儀市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太疫苗管瓶監測儀市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲疫苗管瓶監測儀市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Cardinal Health, Inc.
  • Catalent, Inc.
  • Corning Incorporated
  • DWK Life Sciences GmbH
  • Elitech Technology, Inc.
  • ELPRO-BUCHS AG
  • EVIGENCE SENSORS Inc.
  • Gerresheimer AG
  • Lisaline Lifescience Technologies Pvt Ltd.
  • Nipro Corporation
  • Pacific Vial Manufacturing Inc.
  • Schott AG
  • Stevanato Group
  • Temptime Corporation by Zebra Technologies Corporation
  • Thermo Fisher Scientific Inc.
Product Code: MRR-FB6C9E792F4C

The Vaccine Vial Monitor Market was valued at USD 224.25 million in 2023, expected to reach USD 275.38 million in 2024, and is projected to grow at a CAGR of 22.89%, to USD 949.27 million by 2030.

Vaccine Vial Monitors (VVMs) are small devices attached to vaccine vials that change color to indicate whether the vaccine has been exposed to heat, thus affecting its potency. The need for VVMs stems from the critical requirement to maintain the cold chain in vaccine distribution to ensure vaccines remain effective. Their application is essential in both developed and developing regions, where maintaining optimal storage conditions is challenging. End-users predominantly include healthcare providers, hospitals, clinics, and government immunization programs. The growth of the VVM market is influenced by increasing vaccination campaigns, rising awareness on the importance of vaccine potency, and technological advancements in monitor sensitivity. Additionally, growing governmental and non-governmental support for immunization programs globally has driven demand. However, challenges such as the high cost of VVM technology and limited awareness about their benefits in some regions may affect market expansion. There is also a reliance on consistent supply chains to ensure the widespread availability of such monitors, which can be disrupted in adverse conditions.

KEY MARKET STATISTICS
Base Year [2023] USD 224.25 million
Estimated Year [2024] USD 275.38 million
Forecast Year [2030] USD 949.27 million
CAGR (%) 22.89%

Opportunities exist in expanding the application of VVMs to other temperature-sensitive pharmaceuticals and increasing penetration in untapped markets, particularly in regions with weaker healthcare infrastructures. Companies can innovate by developing VVMs with digital integration to allow real-time monitoring and data logging, which would support better management of vaccine distribution networks. Research into lower-cost but equally effective materials for VVMs may aid in reducing manufacturing costs, making them more accessible. The nature of the VVM market is competitive, with room for collaboration between tech firms and healthcare providers to enhance device features. Businesses can strategically expand by investing in training programs to improve stakeholder knowledge and by leveraging partnerships to strengthen distribution channels, catering particularly to regions with extreme temperature conditions where the demand for VVMs is crucial.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Vaccine Vial Monitor Market

The Vaccine Vial Monitor Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Demand for administration and importance to the safe use of the vaccines
    • Need for adequate monitoring of vaccine vials
    • High prevalence of infectious diseases and a growing number of initiatives to promote immunization
  • Market Restraints
    • Issues associated with applications, and logistics
  • Market Opportunities
    • Relationship between vaccine vial monitors and cold chain infrastructure
    • Increasing healthcare sector efforts towards improving accessibility of medical services in remote areas
  • Market Challenges
    • Stingent regulatory consideration for VVM

Porter's Five Forces: A Strategic Tool for Navigating the Vaccine Vial Monitor Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Vaccine Vial Monitor Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Vaccine Vial Monitor Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Vaccine Vial Monitor Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Vaccine Vial Monitor Market

A detailed market share analysis in the Vaccine Vial Monitor Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Vaccine Vial Monitor Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Vaccine Vial Monitor Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Vaccine Vial Monitor Market

A strategic analysis of the Vaccine Vial Monitor Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Vaccine Vial Monitor Market, highlighting leading vendors and their innovative profiles. These include Cardinal Health, Inc., Catalent, Inc., Corning Incorporated, DWK Life Sciences GmbH, Elitech Technology, Inc., ELPRO-BUCHS AG, EVIGENCE SENSORS Inc., Gerresheimer AG, Lisaline Lifescience Technologies Pvt Ltd., Nipro Corporation, Pacific Vial Manufacturing Inc., Schott AG, Stevanato Group, Temptime Corporation by Zebra Technologies Corporation, and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Vaccine Vial Monitor Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Multi-Dose and Single Dose.
  • Based on Application, market is studied across Preventive Vaccine and Therapeutic Vaccine.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Demand for administration and importance to the safe use of the vaccines
      • 5.1.1.2. Need for adequate monitoring of vaccine vials
      • 5.1.1.3. High prevalence of infectious diseases and a growing number of initiatives to promote immunization
    • 5.1.2. Restraints
      • 5.1.2.1. Issues associated with applications, and logistics
    • 5.1.3. Opportunities
      • 5.1.3.1. Relationship between vaccine vial monitors and cold chain infrastructure
      • 5.1.3.2. Increasing healthcare sector efforts towards improving accessibility of medical services in remote areas
    • 5.1.4. Challenges
      • 5.1.4.1. Stingent regulatory consideration for VVM
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vaccine Vial Monitor Market, by Type

  • 6.1. Introduction
  • 6.2. Multi-Dose
  • 6.3. Single Dose

7. Vaccine Vial Monitor Market, by Application

  • 7.1. Introduction
  • 7.2. Preventive Vaccine
  • 7.3. Therapeutic Vaccine

8. Americas Vaccine Vial Monitor Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Vaccine Vial Monitor Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Vaccine Vial Monitor Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Cardinal Health, Inc.
  • 2. Catalent, Inc.
  • 3. Corning Incorporated
  • 4. DWK Life Sciences GmbH
  • 5. Elitech Technology, Inc.
  • 6. ELPRO-BUCHS AG
  • 7. EVIGENCE SENSORS Inc.
  • 8. Gerresheimer AG
  • 9. Lisaline Lifescience Technologies Pvt Ltd.
  • 10. Nipro Corporation
  • 11. Pacific Vial Manufacturing Inc.
  • 12. Schott AG
  • 13. Stevanato Group
  • 14. Temptime Corporation by Zebra Technologies Corporation
  • 15. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. VACCINE VIAL MONITOR MARKET RESEARCH PROCESS
  • FIGURE 2. VACCINE VIAL MONITOR MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. VACCINE VIAL MONITOR MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. VACCINE VIAL MONITOR MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. VACCINE VIAL MONITOR MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VACCINE VIAL MONITOR MARKET DYNAMICS
  • TABLE 7. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY MULTI-DOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY PREVENTIVE VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VACCINE VIAL MONITOR MARKET SIZE, BY THERAPEUTIC VACCINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 16. ARGENTINA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. ARGENTINA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. BRAZIL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. BRAZIL VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. CANADA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. CANADA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. MEXICO VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. MEXICO VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES VACCINE VIAL MONITOR MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 30. AUSTRALIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. AUSTRALIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. CHINA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CHINA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. INDIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDONESIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDONESIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. JAPAN VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. JAPAN VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. MALAYSIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. MALAYSIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. PHILIPPINES VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. PHILIPPINES VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. SINGAPORE VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SINGAPORE VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SOUTH KOREA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SOUTH KOREA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. TAIWAN VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. TAIWAN VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. THAILAND VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. THAILAND VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. VIETNAM VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. VIETNAM VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 57. DENMARK VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. DENMARK VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. EGYPT VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. EGYPT VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. FINLAND VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FINLAND VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FRANCE VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FRANCE VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. GERMANY VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. GERMANY VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ISRAEL VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ISRAEL VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ITALY VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ITALY VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. NETHERLANDS VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NETHERLANDS VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NIGERIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NIGERIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NORWAY VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NORWAY VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. POLAND VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. POLAND VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. QATAR VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. QATAR VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. RUSSIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. RUSSIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SAUDI ARABIA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SAUDI ARABIA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SOUTH AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH AFRICA VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SPAIN VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SPAIN VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SWEDEN VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWEDEN VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWITZERLAND VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWITZERLAND VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. TURKEY VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. TURKEY VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED ARAB EMIRATES VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED ARAB EMIRATES VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED KINGDOM VACCINE VIAL MONITOR MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED KINGDOM VACCINE VIAL MONITOR MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. VACCINE VIAL MONITOR MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 100. VACCINE VIAL MONITOR MARKET, FPNV POSITIONING MATRIX, 2023